Muralidhar Bali

Average Profitability
<0.0001%
Insider Buys Quantity
14
Insider Buys Sum
$10.19M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Muralidhar Bali

The largest purchase of all time was on 2021-04-13 and amounted to 200000 shares of Reneo Pharmaceuticals, Inc. for $3M.

Biography of Muralidhar Bali

No biography is available at this moment.

2022-05-19PurchaseExicure, Inc.
XCUR
1.47M
1.7441%
$0.19$285,151-61.43%
2021-07-14PurchaseReneo Pharmaceuticals, Inc.
RPHM
director
111,736
0.4501%
$8.50$949,756-25.14%
2021-06-23PurchaseReneo Pharmaceuticals, Inc.
RPHM
director
20,710
0.0938%
$9.28$192,245-28.36%
2021-06-22PurchaseReneo Pharmaceuticals, Inc.
RPHM
director
14,615
0.0653%
$8.72$127,487-24.78%
2021-06-21PurchaseReneo Pharmaceuticals, Inc.
RPHM
director
32,659
0.159%
$9.03$294,927-20.74%
2021-06-08PurchaseReneo Pharmaceuticals, Inc.
RPHM
director
16,605
0.0767%
$9.50$157,709-27%
2021-06-04PurchaseReneo Pharmaceuticals, Inc.
RPHM
director
257
0.0012%
$9.42$2,422-26.44%
2021-06-03PurchaseReneo Pharmaceuticals, Inc.
RPHM
director
12,100
0.0568%
$9.25$111,943-22.32%
2021-05-28PurchaseReneo Pharmaceuticals, Inc.
RPHM
director
14
<0.0001%
$9.50$133-27.26%
2021-05-27PurchaseReneo Pharmaceuticals, Inc.
RPHM
director
1,120
0.005%
$9.26$10,369-23.5%
2021-05-26PurchaseReneo Pharmaceuticals, Inc.
RPHM
director
5,915
0.0276%
$9.38$55,495-21.47%
2021-04-13PurchaseReneo Pharmaceuticals, Inc.
RPHM
director
200,000
1.1482%
$15.00$3M-34.38%
2020-10-14PurchaseSpruce Biosciences, Inc.
SPRB
director
200,000
0.7802%
$15.00$3M-10.92%
2019-12-19PurchaseExicure, Inc.
XCUR
director
727,000
0.8229%
$2.75$2M-22.94%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.